Latest News

FDA Approves First Drug for Multicentric Castleman's Disease

FDA Approves First Drug for Multicentric Castleman's Disease

Janssen Biotech announced that the FDA has approved Sylvant (siltuximab) for the treatment of patients with multicentric Castleman's disease (MCD) who are HIV negative and HHV-8 negative.

The Future of Clinical Trials: 'Smaller and Smarter'

The Future of Clinical Trials: 'Smaller and Smarter'

The time has come to "raise the bar" in cancer clinical trials.

FDA Grants Fast Track Designation for Custirsen for mCRPC

FDA Grants Fast Track Designation for Custirsen for mCRPC

The FDA granted Fast Track designation to custirsen when given in combination with cabazitaxel/prednisone for the treatment of metastatic castration-resistant prostate cancer (mCRPC) after prior treatment with a docetaxel-containing regimen.

Alvocidib Receives Orphan Drug Designation for AML

Alvocidib Receives Orphan Drug Designation for AML

The FDA has granted Orphan Drug designation to alvocidib for the treatment of patients with acute myeloid leukemia.

Combined Tobacco, Alcohol Use Spikes Esophageal Cancer Risk

Combined Tobacco, Alcohol Use Spikes Esophageal Cancer Risk

Rates of esophageal squamous cell carcinoma (ESCC) nearly double for those who use tobacco and consume alcohol, compared to individuals who only smoke or drink.

More News

8 Million People Signed Up for Health Insurance

Eight million Americans signed up for private health insurance during the just-concluded first enrollment period under the Affordable Care Act.

New Health Secretary to Face Health Care Reform Hurdles

With the resignation of U.S. Health and Human Services Secretary Kathleen Sebelius on Friday, the Affordable Care Act will get a fresh face.

Fewer Americans Overwhelmed by Medical Bills

While millions of Americans still feel hamstrung by medical expenses, a new government report shows that some people are getting relief.

Sebelius Resigns as HHS Secretary

US Health and Human Services Secretary Kathleen Sebelius is stepping down from her position, after overseeing the troubled rollout of the Affordable Care Act.

Medicare Paid Some Docs $3 Million Each in 2012

A small number of doctors received at least $3 million each in Medicare payments in 2012, for a total of nearly $1.5 billion.

Majority of Women Lack Accurate Knowledge of Their Own Breast Cancer Risk

Caucasian women overestimate their risk of breast cancer while African American and Hispanic women underestimate their risk, according to research presented at BCS 2013.

Survey Identifies Modifiable Barriers to Mammography Screening Among Rural US Women

A survey presented at BCS 2013 has found a number of factors that cause rural US women to avoid breast cancer screening.

Perioperative MRI of Uncertain Benefit for Women with DCIS

The benefit of perioperative MRI for women with ductal carcinoma in situ (DCIS) is "uncertain," found a study presented during BCS 2013.

Dr. Edith Perez's Recommended Abstracts at BCS 2013

ChemotherapyAdvisor.com Editorial Board member Dr. Edith Perez of the Mayo Clinic, Jacksonville, FL, recommends high impact abstracts at the Breast Cancer Symposium 2013.

Radiotherapy for DCIS Is Not Associated With Increased Cardiovascular Disease

Women who underwent radiation for ductal carcinoma in situ do not face an increased risk of cardiovascular disease, found a study presented at BCS 2013.

Statins Reduce Kidney Cancer Progression

Reduced risk of progression of localized renal cell carcinoma observed in patients on statins.

Prostate Cancer Adherence to Quality of Care Measures Frequently Low

Regional variation seen in pretreatment counseling, overuse of bone scans, oncologist follow-up.

Prostate Brachytherapy On the Decline

Use of this treatment for localized prostate cancer has been decreasing since 2002, perhaps due to increasing use of radical prostatectomy.

Adding ADT to Radiotherapy Improves Prostate Cancer Outcomes

The combined treatment was associated with a reduced risk of biochemical and clinical progression compared with radiotherapy alone.

Osteoporosis May Be Present Before Prostate Cancer ADT

Danish study reveals a 10% prevalence of osteoporosis among men due to start androgen-deprivation therapy.

Sign Up for Free e-newsletters

Enter Our April Contest

Start the contest today

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs